- gemtuzumab ozogamicin
Wikipedia foundation.
gemtuzumab ozogamicin
Look at other dictionaries:
Gemtuzumab ozogamicin — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD33 Clinical data Trade names Mylotarg AHFS/ … Wikipedia
Gemtuzumab-Ozogamicin — Masse/Länge Primärstruktur 151 bis 153 kDa … Deutsch Wikipedia
Gemtuzumab ozogamicin — Größe 151 bis 153 kDa Bezeichner Externe IDs … Deutsch Wikipedia
gemtuzumab ozogamicin — A monoclonal antibody combined with a toxic substance that is used treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory… … English dictionary of cancer terms
gemtuzumab ozogamicin — gem·tu·zu·mab ozo·ga·mi·cin (gem tooґzoo mab″ o″zo gə miґsin) a recombinant DNA–derived monoclonal antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin, isolated from the bacterium Micromonospora echinospora … Medical dictionary
Gemtuzumab — ozogamicin Größe 151 bis 153 kDa Bezeichner Externe IDs … Deutsch Wikipedia
Ozogamicin — The term ozogamicin in the names of monoclonal antibodies or antibody drug conjugates indicates that they are linked to a cytotoxic agent from the class of calicheamicins, as in: Gemtuzumab ozogamicin Inotuzumab ozogamicin This disambiguation… … Wikipedia
gemtuzumab — A monoclonal antibody combined with a toxic substance that is used treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory… … English dictionary of cancer terms
Inotuzumab ozogamicin — drugbox type = mab source = Humanized target = CD22 CAS number = 635715 01 4 ATC prefix = ATC suffix = PubChem = DrugBank = C=6518 | H=10002 | N=1738 | O=2036 | S=42 molecular weight = bioavailability = protein bound = metabolism = elimination… … Wikipedia
Cancer immunotherapy — is the use of the immune system to reject cancer. The main premise is stimulating the patient s immune system to attack the malignant tumor cells that are responsible for the disease. This can be either through immunization of the patient, in… … Wikipedia
